academic根拠レベル B独立情報源
根拠ページBrava and autologous fat transfer is a safe and effective breast augmentation alternative: results of a 6-year, 81-patient, prospective multicenter study (Khouri RK, … ; Plast Reconstr Surg 2012;129(5):1173-1187)
Plastic and Reconstructive Surgery
閲覧日 2026年11月9日更新 2026年11月9日
原典
https://pubmed.ncbi.nlm.nih.gov/22261565/
pubmed.ncbi.nlm.nih.gov
検証
| 検証 | 対象から独立した出典 |
| 根拠レベル | B · 査読・専門団体 |
| 独立情報源 | 対象から独立した情報源 |
| 出典 | academic |
| リンク状態 | 最終確認時にアクセス可能 |
公式な主張は提供者の声明であり、特に記載がない限りworldwikiが検証したものではありません。 出典ポリシー
引用元ページ (2)
Answer나이가 많거나 폐경 전후면 가슴 지방이식 생착률이 낮아지나요?“In a prospective multicenter study, 81 women (age range, 17 to 63 years) wore the Brava device, a bra-like vacuum-based external tissue expander, for 4 weeks and then underwent autologous fat injection”Answer한 번에 300cc 이상 넣는 대용량 가슴 지방이식은 가능한가요? 조건과 위험은 무엇인가요?“In a prospective multicenter study, 81 women (age range, 17 to 63 years) wore the Brava device, a bra-like vacuum-based external tissue expander, for 4 weeks and then underwent autologous fat injection using 10 to 14 needle puncture sites into each breast in a three-dimensional fanning pattern (average, 277 ml volume injected per breast). … had a mean augmentation volume at 12 months of 233 ml per breast compared with 134 ml per breast in published series without Brava (p < 0.00001). Graft survival was 82 ± 18 percent compared with 55 ± 18 percent without Brava (p < 0.00001). … Magnetic resonance imaging recognized a 16 percent incidence of fat necrosis easily identified at 1-year mammographic evaluation.”